Carl-Magnus Högerkorp has been appointed chief executive of Cyxone AB, a Swedish company developing therapies for autoimmune diseases. He has been acting CEO since June 2022. Dr Högerkorp, who holds a PhD in immunology and a masters’ degree in business administration, has previously been CEO of Canimguide Therapeutics AB, an oncology company, and Edvince AB, a company working on treatments for stroke. He has also been a principal scientist at Novo Nordisk A/S of Denmark.
Cyxone announced the appointment on 20 December 2022.
Copyright 2023 Evernow Publishing Ltd